Antioxidant and Antidiabetic Enzyme Inhibitory Activities of the Ethyl Acetate Fraction of Ocimum gratissimum Leaf Methanol Extract
Clicks: 2
ID: 311597
2025
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
0.3
/100
2 views
1 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #144 of 254 articles by views in Yemen Journal of Medicine
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 254 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Background: Natural products remain an important source of bioactive compounds for the management of metabolic disorders. This study aimed to investigate the antidiabetic and antioxidant potential of the ethyl acetate fraction of Ocimum gratissimum leaves (EAFOGL) through in vitro enzyme inhibition assays, antioxidant assays, and molecular docking analyses, to identify the phytochemicals responsible for the observed bioactivities.
Methods: EAFOGL was evaluated for α-amylase and α-glucosidase inhibitory activities and antioxidant potential using radical scavenging and metal chelation assays. Molecular docking was performed for selected phytochemicals against α-amylase (PDB ID: 1B2Y), α-glucosidase (PDB ID: 2QMJ), and xanthine oxidase (PDB ID: 3NVY). Docking protocol validation was achieved by re-docking native ligands, and binding affinities and protein–ligand interactions were analysed.
Results: EAFOGL exhibited moderate inhibition of α-amylase (IC50 = 87.17 ± 5.20 μg/mL) and α-glucosidase (IC50 = 49.84 ± 6.72 μg/mL) compared with acarbose (IC50 = 52.12 ± 2.74 and 40.94 ± 3.44 μg/mL, respectively). The fraction also demonstrated notable radical scavenging (IC50 = 90.32 ± 9.91 μg/mL) and metal chelating (IC50 = 98.58 ± 13.29 μg/mL) activities, although less potent than ascorbic acid and Ethylenediaminetetraacetic acid (EDTA). Docking validation yielded root mean square deviation values below 2.0 Å, confirming docking reliability. Among the screened compounds, rosmarinic acid isomers showed favourable binding energies and strong interactions with key catalytic residues of all three enzymes. Notably, cis-rosmarinic acid exhibited the highest affinity toward xanthine oxidase (−7.558 kcal/mol), exceeding that of the native ligand quercetin.
Conclusions: The findings demonstrate that EAFOGL possesses moderate antidiabetic and antioxidant activities, supported by molecular docking results identifying rosmarinic acid derivatives as key contributors to enzyme inhibition. These results highlight EAFOGL as a promising source of bioactive compounds for managing oxidative stress and postprandial hyperglycaemia.
| Reference Key |
lawal2026antioxidant
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Tajudeen Afolayan Lawal, Qazeem Oyeniyi Sholadoye |
| Journal | Yemen Journal of Medicine |
| Year | 2025 |
| DOI |
10.63475/yjm.v4i3.0244
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.